Opicapone 50 mg
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Opicapone 50 mg, covering 2023-06-01 to 2023-06-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD [Phase 4]